Shattuck Labs, Inc. Increase (Decrease) in Accounts Payable
Shattuck Labs, Inc. (STTK) reported Increase (Decrease) in Accounts Payable of $1.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- Shattuck Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.52M.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$911.00K.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $939.00K.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $687.00K, a 497.39% increase year-over-year.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$318.00K, a 138.22% decline from fiscal 2024.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for fiscal 2024 was $832.00K.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$5.63M.
- Shattuck Labs, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$2.84M, a 136.13% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.61M 10-Q · filed 2026-08-11 | $2.55M derived: sum of 3 quarters · filed 2026-08-11 | $3.24M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$911.00K 10-Q · filed 2026-05-07 | $28.00K derived: sum of 2 quarters · filed 2026-05-07 | $715.00K derived: sum of 3 quarters · filed 2026-05-07 | -$343.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $939.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.63M derived: sum of 2 quarters · filed 2026-03-05 | $568.00K derived: sum of 3 quarters · filed 2026-08-11 | -$318.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$371.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.26M 10-Q · filed 2025-11-06 | -$1.76M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.94M 10-Q · filed 2026-08-11 | -$2.45M derived: sum of 3 quarters · filed 2026-08-11 | -$2.34M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$886.00K 10-Q · filed 2026-05-07 | -$1.39M derived: sum of 2 quarters · filed 2026-05-07 | -$1.28M derived: sum of 3 quarters · filed 2026-05-07 | -$960.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$393.00K derived: sum of 2 quarters · filed 2026-03-05 | -$74.00K derived: sum of 3 quarters · filed 2026-03-05 | $832.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $434.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.34M 10-Q · filed 2025-11-06 | $865.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.23M 10-Q · filed 2025-08-14 | $750.00K derived: sum of 3 quarters · filed 2025-08-14 | $770.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $906.00K 10-Q · filed 2025-05-01 | $431.00K derived: sum of 2 quarters · filed 2025-05-01 | $451.00K derived: sum of 3 quarters · filed 2025-05-01 | -$2.53M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | -$475.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$455.00K derived: sum of 2 quarters · filed 2025-03-27 | -$3.43M derived: sum of 3 quarters · filed 2025-03-27 | -$5.63M 10-K · filed 2025-03-27 |
| 2023-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.96M derived: sum of 2 quarters · filed 2024-11-14 | -$5.15M 10-Q · filed 2024-11-14 | -$799.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$5.17M 10-Q · filed 2024-08-01 | -$819.00K derived: sum of 3 quarters · filed 2024-08-01 | -$3.49M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$2.20M 10-Q · filed 2024-05-02 | $2.16M derived: sum of 2 quarters · filed 2024-05-02 | -$517.00K derived: sum of 3 quarters · filed 2024-05-02 | $2.70M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.68M derived: sum of 2 quarters · filed 2024-02-29 | $4.90M derived: sum of 3 quarters · filed 2024-02-29 | -$2.84M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $541.00K derived: sum of 2 quarters · filed 2023-11-09 | -$7.20M 10-Q · filed 2023-11-09 | -$177.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.52M 10-Q · filed 2023-08-10 | $2.50M derived: sum of 3 quarters · filed 2023-08-10 | $4.25M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$7.74M 10-Q · filed 2023-05-09 | -$718.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.03M derived: sum of 3 quarters · filed 2023-05-09 | -$1.11M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.77M derived: sum of 2 quarters · filed 2023-02-23 | $6.63M derived: sum of 3 quarters · filed 2023-02-23 | $7.87M 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$395.00K derived: sum of 2 quarters · filed 2022-11-09 | $846.00K 10-Q · filed 2022-11-09 | $796.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$903.00K 10-Q · filed 2022-08-11 | -$953.00K derived: sum of 3 quarters · filed 2022-08-11 | -$707.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-12 | $1.19M derived: sum of 2 quarters · filed 2022-05-12 | $1.44M derived: sum of 3 quarters · filed 2022-05-12 | $940.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $196.00K derived: sum of 2 quarters · filed 2022-03-15 | -$301.00K derived: sum of 3 quarters · filed 2022-03-15 | -$1.75M 10-K · filed 2022-03-15 |
| 2020-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$251.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.70M 10-Q · filed 2021-11-09 | $525.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$497.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.95M 10-Q · filed 2021-08-12 | $279.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$1.45M 10-Q · filed 2021-05-10 | $776.00K derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.00M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$1.22M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |